References
- Mason M. What implications do the tolerability profiles of antiandrogens and other commonly used prostate cancer treatments have on patient care? J Cancer Res Clin Oncol 2006;132(Suppl 13):27–35
- Jenkins V, Fallowfield L, Saul J. Information needs of patients with cancer: results from a large study in UK cancer centres. Br J Cancer 2001;84:48–51
- Davison BJ, Parker PA, Goldenberg SL. Patients’ preferences for communicating a prostate cancer diagnosis and participating in medical decision-making. BJU Int 2004;93:47–51
- Lloyd A, Penson D, Dewilde S, Kleinman L. Eliciting patient preferences for hormonal therapy options in the treatment of metastatic prostate cancer. Prostate Cancer Prostatic Dis 2007; e-pub ahead of print, doi:10.1038/sj.pcan.4500992.
- Litwin MS, Hays RD, Fink A, et al. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA 1995;273: 129–35
- Madalinska JB, Essink-Bot ML, de Koning HJ, et al. Health-related quality-of-life effects of radical prostatectomy and primary radiotherapy for screen-detected or clinically diagnosed localized prostate cancer. J Clin Oncol 2001;19: 1619–28
- Clark JA, Inui TS, Silliman RA, et al. Patients’ perceptions of quality of life after treatment for early prostate cancer. J Clin Oncol 2003;21:3777–84
- Korfage IJ, Hak T, de Koning HJ, Essink-Bot ML. Patients’ perceptions of the side-effects of prostate cancer treatment – a qualitative interview study. Soc Sci Med 2006;63:911–19
- Clark JA, Rieker P, Propert KJ, Talcott JA. Changes in quality of life following treatment for early prostate cancer. Urology 1999;53:161–8
- SEER Stat Fact Sheets - Cancer of the Prostate [online]. Available from http://seer.cancer.gov/statfacts/html/prost.html?statfacts_page=prost.html&x=2&y=11 [Accessed 18 Jun 2007]
- AF Cancer Research UK. UK Prostate Cancer incidence statistics [online]. Available from http://info.cancerresearchuk.org/cancerstats/types/prostate/incidence/ [Accessed 18 Jun 2007]